Brief: Eurocine Vaccines: First Nasal Influenza Vaccine Approved For Children Under 2
Dec 11 (Reuters) - Eurocine Vaccines Ab EUCI.TE :
* SAYS CREATES FIRST NASAL INFLUENZA VACCINE APPROVED FOR
CHILDREN UNDER AGE OF TWO.
Source text for Eikon: ID:nWkr7gmdGb
Further company coverage: EUCI.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Nidhogg Resources Holding AB (publ)
See all newsBrief: Nidhogg Resources Holding Resolves On A Directed Set-Off Share Issue
Brief: Nidhogg Resources Holding AB Announces The Termination Of The Al Baraka Project In Egypt
Brief: Eurocine Vaccines Q4 EPS at SEK -0.111
Brief: Eurocine Vaccines Says Decides To Develop mRNA-Based Vaccine Candidate Against Chlamydia
Brief: Eurocine Vaccines Expands Its Portfolio With A Therapeutic Hsv-2 Vaccine Candidate